Gufic Biosciences Files SEBI Compliance Certificate for Q4 FY26
Gufic Biosciences Limited submitted a compliance certificate for the quarter ended March 31, 2026, as per SEBI regulations. The RTA confirmed processing of dematerialized securities and no shareholder requests were received during the period.
This is a standard compliance filing required by SEBI, with no new material information that would significantly affect the company's operations or stock performance.
The announcement is a routine regulatory filing and does not contain any new financial or business-related information that would impact the company's outlook.
Gufic Biosciences Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. This compliance certificate was received from M/s. MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent (RTA).
The RTA confirmed that securities received from depository participants for dematerialization during the quarter were processed and listed on the stock exchanges. The security certificates were duly verified, mutilated, and cancelled, with the depositories' names substituted in the register of members within the prescribed timelines.
Notably, MUFG Intime India Private Limited stated that no requests were received from shareholders during the quarter ended March 31, 2026, and the certificate was issued for compliance purposes. The submission was made to BSE Limited and the National Stock Exchange of India Limited.
What to do with a filing like this
Gufic Biosciences Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gufic Biosciences Limited. Read the original for the full detail.